TrialThe lancet. HIV2019

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

Evgeny Krupitsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.